Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trialsJeffrey S. Heier|The Lancet|2023Cited by 420
TENAYA and LUCERNEArshad M. Khanani, Stuart C Burgess, Shih‐Jen Chen et al.|Ophthalmology|2024Cited by 173